References

References:

  1. De Jager LJ, Schubert PT, Baatjes K, Conradie W, Edge J. A comparison of invasive lobular carcinoma with other invasive breast cancers at Tygerberg Academic Hospital. South African Journal of Surgery. 2022;60(3):176–81. 2.
  2. Wilson N, Ironside A, Diana A, Oikonomidou O. Lobular Breast Cancer: A Review. Front Oncol. 2021;10:591399.
  3. Foroozani E, Akbari A, Amanat S, et al. Adherence to a western dietary pattern and risk of invasive ductal and lobular breast carcinomas: a case-control study. Sci Rep. 2022;12(1):5859.
  4. Cibas E, Ducatman B. Cytology: Diagnostic Principles and Clinical Correlates. 3rd ed. Philadelphia: Elsevier: 2009. p222–256.
  5. Kumar V, Abbas A, Aster J. Pathologic basis of disease. In: Turner J, editor. 10th edition. Philadelphia: Jeremy Bowes: 2021. p1075–92.
  6. Christgen M, Cserni G, Floris G, Marchio C. Lobular Breast Carcinoma: Histomorphology and Different Concepts of a Special Spectrum of Tumors. Cancers (Basel). 2021 Jul;13(15):3695.
  7. Findlay-Shirras L, Lima I, Smith G, Clemons M, Arnaout A. Population Trends in Lobular Carcinoma of the Breast: The Ontario Experience. Ann Surg Oncol. 2020 Nov;27(12):4711–9.
  8. Mukhtar, R.A., Chien, A.J. Invasive Lobular Carcinoma of the Breast: Ongoing Trials, Challenges, and Future Directions. Curr Breast Cancer Rep. 2021;13:164–170.
  9. Costantini M, Montella RA, Fadda MP, et al. Diagnostic Challenge of Invasive Lobular Carcinoma of the Breast: What Is the News? Breast Magnetic Resonance Imaging and Emerging Role of Contrast-Enhanced Spectral Mammography. J Pers Med. 2022;12(6):867.
  10. Klumpp LC, Shah R, Syed N, Fonseca G, Jordan J. Invasive Lobular Breast Carcinoma Can Be a Challenging Diagnosis Without the Use of Tumor Markers. Cureus. 2020;12(5):8376.
  11. Ail S, Parwani A. Breast Cytopathology. In: Rosenthal D, editor. New York: Springer: 2007. p138–150.
  12. Menet E, Becette V, Briffod M. Cytologic diagnosis of lobular carcinoma of the breast: Experience with 555 patients in the Rene Huguenin Cancer Center. Cancer. 2008 Apr 25;114(2):111–7.
  13. Hrizat A, Brachtel E. Metastatic Breast Cancer: Cytology Diagnosis with Implications for Treatment. Journal of Molecular Pathology. 2022 Dec 24;4(1):1–14.
  14. Chandra A, Crothers B, Daniel Kurtycz, Schmitt F. The International System for Serous Fluid Cytopathology. In: Chandra A, Crothers B, Kurtycz D, Schmitt F, editors. Switzerland: Springer: 2020. p223–224.
  15. Li S, Li C, Shao W, Liu X, Sun L, Yu Z. Survival analysis and prognosis of patients with breast cancer with pleural metastasis. Front Oncol. 2023;13:1104246.
  16. Roa R, Hoda S, Marcus A, Hoda R. Metastatic Breast Carcinoma in Cerebrospinal Fluid: A Cytopathological Review of 15 Cases. Breast J. 2017 Jul;23(4):456–60.
  17. Qayyum A, Birdwell RL, Daniel BL, Nowels KW, Jeffrey SS, Agoston TA, et al. MR imaging features of infiltrating lobular carcinoma of the breast. American Journal of Roentgenology. 2002;178(5):1227–32.
  18. Jayaram G, Swain M, Chew M, Yip C. Cytologic Appearances in Invasive Lobular Carcinoma of the Breast: A Study of 21 Cases. Acta Cytol. 2000;44(2):169–74.
  19. McCart Reed AE, Kutasovic JR, Lakhani SR, Simpson PT. Invasive lobular carcinoma of the breast: morphology, biomarkers and 'omics. Breast Cancer Res. 2015;17(1):12.
  20. Field A, Raymond W, Schmitt F. The International Academy of Cytology Yokohama System for Reporting Breast Fine Needle Aspiration Biopsy Cytopathology. In: Field A, Schmitt F, Raymond W, editors. Australia: Springer: 2020.
  21. Goldblum J, Lamps L, McKenny J, Myers J. Rosai and Ackerman’s Surgical Pathology . 11th ed. Vol. 1. Philadelphia: Elsevier: 2018. p278–354.
  22. Simpson P, Reis-Filho J, Lambros M, Jones C, Steele D, Mackay A, et al. Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas. J Pathol. 2008 Jul;215(3):231–44.
  23. Ciriello G, Gatza ML, Beck AH, Wilkerson MD, Rhie SK, Pastore A, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506–19.
  24. Akçay MN. Metastatic disease in the breast. Breast. 2002;11(6):526-528.
  25. Mirkheshti N, Mohebtash M. A rare case of bilateral breast lobular carcinoma coexisting with primary breast follicular lymphoma. J Community Hosp Intern Med Perspect. 2019 Mar 4;9(2):155–8.
  26. Kini S. Color Atlas of Differential Diagnosis in Exfoliative and Aspiration Cytology. In: Pinc J, editor. Philadelphia: Lippincott Williams & Wilkins: 2011.p 688–730.
  27. Netra S, Vani B, Murthy V. Cytomorphological Study of Medullary Carcinoma of Breast in Comparison to Infiltrating Ductal Carcinoma. J Cytol. 2018 Nov;35(4):195–8.
  28. Sakhri S, Aloui M, Bouhani M, et al. Primary breast lymphoma: a case series and review of the literature. J Med Case Rep. 2023;17(1):290.
  29. Uenaka N, Yamamoto S, Sato S, et al. Primary breast lymphoma initially diagnosed as invasive ductal carcinoma: A case report. Clin Case Rep. 2021;9(6):04189.
  30. Ishida M, Iwai M, Yoshida K, Kagotani A, Okabe H. Signet-ring cell melanoma with sentinel lymph node metastasis: A case report with immunohistochemical analysis and review of the clinicopathological features. Oncol Lett. 2014;7(1):65–8.
  31. Teixido C, Castillo P, Martinez-Vila C, Arance A, Alos L. Molecular Markers and Targets in Melanoma. Cells. 2021;10(9):2320.
  32. Mohanty SK, Kim SA, DeLair DF, Bose S, Laury AR, Chopra S, et al. Comparison of metastatic neuroendocrine neoplasms to the breast and primary invasive mammary carcinomas with neuroendocrine differentiation. Modern Pathology. 2016 Aug 1;29(8):788–98.
  33. Saad RS, Ghorab Z, Khalifa MA, Xu M. CDX2 as a marker for intestinal differentiation: Its utility and limitations. World J Gastrointest Surg. 2011;3(11):159-166.